P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL

• A. Röth,
• J. Panse,
• B. Gentile,
• M. Buri,
• H. Patel,
• Z. Nagy

Affiliations

A. Röth

1 Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen

J. Panse

2 University Hospital RWTH Aachen, Aachen, Germany

B. Gentile

3 Genentech, Inc., South San Francisco, CA, United States of America

M. Buri

4 F. Hoffmann-La Roche Ltd., Basel, Switzerland

H. Patel

3 Genentech, Inc., South San Francisco, CA, United States of America

Z. Nagy

5 Semmelweis University, Budapest, Hungary